RHAG and neoplasm: Rh2 inhibits tumor tissue growth by inhibiting the proliferation of tumor cells, inducing apoptosis (Zhuang et al., 2018), inhibiting tumor invasion (Li et al., 2015), migration and angiogenesis (Chen et al., 2018), and reversing/delaying multidrug resistance (Wen et al., 2015).